WCDD301 does not affect the secretory function of cells over a range of concentrations (Figure 2, DF), and WCDD301 administration achieves euglycemia without clinical signs of illness, hepatotoxicity, or nephrotoxicity (Supplemental Table 2)
California Prop 65 Notice: WARNING: Consuming this product can expose you to chemicals including those listed under California Proposition 65 (Prop 65)
In TRIUMPH-1, participants on 12 mg lost an average of 28.3% of their body weight approximately 70 pounds over 80 weeks
Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, et al
Inject 30 minutes before sleep as usual, but structure your post-workout nutrition carefully